BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7145776)

  • 1. Human prostatic tissue concentrations of rosoxacin.
    Jensen KM; Patel RB; Welling PG; Madsen PO
    Prostate; 1982; 3(5):523-9. PubMed ID: 7145776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of quinoline carboxylic acid derivatives in the dog prostate.
    Jensen KM; Madsen PO
    Prostate; 1983; 4(4):407-14. PubMed ID: 6223287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of ciprofloxacin in the dog prostate and various tissues.
    Frimodt-Møller PC; Dørflinger T; Madsen PO
    Urol Res; 1984; 12(6):283-6. PubMed ID: 6240821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosoxacin distribution in kidney and prostate: experimental studies in dogs.
    Maigaard S; Frimodt-Möller N; Madsen PO
    Urol Res; 1980; 8(2):113-6. PubMed ID: 7394950
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosoxacin and cinoxacin distribution in prostate, vagina, and female urethra. An experimental study in dogs.
    Maigaard S; Frimodt-Möller N; Hoyme U; Madsen PO
    Invest Urol; 1979 Sep; 17(2):149-52. PubMed ID: 468515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic analysis of rosoxacin and its N-oxide metabolite in plasma and urine.
    Kullberg MP; Koss R; O'Neil S; Edelson J
    J Chromatogr; 1979 May; 173(1):155-63. PubMed ID: 546869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostatic tissue and fluid levels of lomefloxacin (NY-198)].
    Nasu Y; Nishitani Y; Yamada D; Hayata S; Tsugawa M; Kishi M; Mizuno A; Kumon H; Ohmori H; Nanba K
    Hinyokika Kiyo; 1989 Mar; 35(3):551-6. PubMed ID: 2735259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of rosoxacin in human volunteers.
    Park GB; Saneski J; Weng T; Edelson J
    J Pharm Sci; 1982 Apr; 71(4):461-2. PubMed ID: 7086661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
    Digranes A; Dibb WL; Benonisen E
    Chemotherapy; 1985; 31(6):466-71. PubMed ID: 2934234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.
    Wagenlehner FM; Lunz JC; Kees F; Wieland W; Naber KG
    J Chemother; 2006 Oct; 18(5):485-9. PubMed ID: 17127224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of gonococcal W serogrouping in the evaluation of a clinical trial of rosoxacin.
    Rudén AK; Werner YK; Ringertz O; Bygdeman SM; Bäckman M; Sandström EG
    Sex Transm Dis; 1985; 12(1):19-24. PubMed ID: 3890225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of rufloxacin into human prostatic tissue and fluid.
    Boerema JB; Bach D; Jol C; Pahlmann W
    J Antimicrob Chemother; 1991 Oct; 28(4):547-54. PubMed ID: 1662190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gonorrheal urethritis. Single-dose treatment with rosoxacin].
    Reichardt F; Vogt HJ; Borelli S; Jünger M; Milbradt R
    MMW Munch Med Wochenschr; 1983 May; 125(18):387-8. PubMed ID: 6406876
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical evaluation of rosoxacin for the treatment of chancroid.
    Haase DA; Ndinya-Achola JO; Nash RA; D'Costa LJ; Hazlett D; Lubwama S; Nsanze H; Ronald AR
    Antimicrob Agents Chemother; 1986 Jul; 30(1):39-41. PubMed ID: 3489439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue.
    Naber KG; Sörgel F; Kees F; Schumacher H; Metz R; Grobecker H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():199-207. PubMed ID: 2462556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion of tosufloxacin into prostatic tissue.
    Uchibayashi T; Hisazumi H; Kanayama J; Kumano K
    Chemotherapy; 1992; 38(3):150-4. PubMed ID: 1380905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraprostatic concentration of ciprofloxacin and its activity against urinary pathogens.
    Hoogkamp-Korstanje JA; van Oort HJ; Schipper JJ; van der Wal T
    J Antimicrob Chemother; 1984 Dec; 14(6):641-5. PubMed ID: 6440885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amifloxacin distribution in the dog prostate.
    Frimodt-Møller PC; Dørflinger T; Madsen PO
    Prostate; 1985; 6(2):163-8. PubMed ID: 3975177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enrofloxacin concentrations in dogs with normal prostate and dogs with chronic bacterial prostatitis.
    Dorfman M; Barsanti J; Budsberg SC
    Am J Vet Res; 1995 Mar; 56(3):386-90. PubMed ID: 7771709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Humbert G; Fillastre JP; Grise P
    Am J Med; 1992 Apr; 92(4A):12S-14S. PubMed ID: 1374582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.